These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11560956)

  • 21. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections.
    Rosenits K; Keppler SJ; Vucikuja S; Aichele P
    Eur J Immunol; 2010 Dec; 40(12):3450-7. PubMed ID: 21080375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
    J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate.
    Tian S; Maile R; Collins EJ; Frelinger JA
    J Immunol; 2007 Sep; 179(5):2952-60. PubMed ID: 17709510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.
    Kyburz D; Aichele P; Speiser DE; Hengartner H; Zinkernagel RM; Pircher H
    Eur J Immunol; 1993 Aug; 23(8):1956-62. PubMed ID: 8344359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma.
    Chang ML; Chen YT; Su YC; Kung JT
    J Biomed Sci; 2003; 10(6 Pt 1):644-50. PubMed ID: 14576467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection.
    Bachmann MF; Barner M; Viola A; Kopf M
    Eur J Immunol; 1999 Jan; 29(1):291-9. PubMed ID: 9933111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the precursor frequency of naive antigen-specific CD8 T cells.
    Blattman JN; Antia R; Sourdive DJ; Wang X; Kaech SM; Murali-Krishna K; Altman JD; Ahmed R
    J Exp Med; 2002 Mar; 195(5):657-64. PubMed ID: 11877489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
    Lu J; Giuntoli RL; Omiya R; Kobayashi H; Kennedy R; Celis E
    Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymus-resident memory CD8+ T cells mediate local immunity.
    Hofmann M; Oschowitzer A; Kurzhals SR; Krüger CC; Pircher H
    Eur J Immunol; 2013 Sep; 43(9):2295-304. PubMed ID: 23715993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment.
    Carrio R; Bathe OF; Malek TR
    J Immunol; 2004 Jun; 172(12):7315-23. PubMed ID: 15187107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein.
    Martin S; Kohler H; Weltzien HU; Leipner C
    J Immunol; 1996 Sep; 157(6):2358-65. PubMed ID: 8805633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.
    Aichele P; Brduscha-Riem K; Oehen S; Odermatt B; Zinkernagel RM; Hengartner H; Pircher H
    Immunity; 1997 May; 6(5):519-29. PubMed ID: 9175830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curtailed T-cell activation curbs effector differentiation and generates CD8
    Zanon V; Pilipow K; Scamardella E; De Paoli F; De Simone G; Price DA; Martinez Usatorre A; Romero P; Mavilio D; Roberto A; Lugli E
    Eur J Immunol; 2017 Sep; 47(9):1468-1476. PubMed ID: 28671275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
    Bachmann MF; Speiser DE; Zakarian A; Ohashi PS
    Eur J Immunol; 1998 Oct; 28(10):3110-9. PubMed ID: 9808179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcineurin Aalpha plays an exclusive role in TCR signaling in mature but not in immature T cells.
    Chan VS; Wong C; Ohashi PS
    Eur J Immunol; 2002 May; 32(5):1223-9. PubMed ID: 11981809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.